SEARCH WITHIN CONTENT
VOLUME 24 , ISSUE S5 ( November, 2020 ) > List of Articles
Dhruva Chaudhry, OC Abraham, Jose Chacko, Jigeeshu Divatia, Bharat Jagiasi, Arindam Kar, GC Khilnani, RK Mani, BK Rao, Pawan K Singh, Sanjeev Singh, Pavan Tiwary, Chand Wattal, Deepak Govil, Subhal Dixit
Keywords : Convalescent plasma, COVID-19, SARS-CoV-2
Citation Information :
License: CC BY-NC 4.0
Published Online: 18-11-2020
Copyright Statement: Copyright © 2020; Jaypee Brothers Medical Publishers (P) Ltd.
The management of coronavirus disease-2019 (COVID-19) is witnessing a change as we learn more about the pathophysiology and the severity of the disease. Several randomized controlled trials (RCTs) and meta-analysis have been published over the last few months. Several interventions and therapies which showed promise in the initial days of the pandemic have subsequently failed to show benefit in well-designed trials. Understanding of the methods of oxygen delivery and ventilation have also evolved over the past few months. The Indian Society of Critical Care Medicine (ISCCM) has reviewed the evidence that has emerged since the publication of its position statement in May and has put together an addendum of updated evidence.
© Jaypee Brothers Medical Publishers (P) LTD.